|
31623.01.02
|
ALECENSA CAPS 150MG/CAP Φιάλη (HDPE) x240 καψάκια
|
|
4.692,21 € |
5.218,82 € |
5.642,59 € |
Roche Registration Ltd
|
|
22731.02.02
|
BONDRONAT C/S.SOL.IN 2MG/2ML BTx1VIALx2ML
|
|
66,72 € |
76,69 € |
108,14 € |
Roche Registration Ltd
|
|
26978.02.02
|
BONVIVA F.C.TAB 150 MG/TAB BTx3(BLIST PVC/PVDC)
|
|
36,02 € |
41,40 € |
58,38 € |
Roche Registration Ltd
|
|
30333.01.02
|
ESBRIET CAPS 267MG/CAP BTx252 (4x63) σε PVC/PE/PCTFE/alu blister
|
|
1.745,17 € |
1.941,00 € |
2.124,32 € |
Roche Registration Ltd
|
|
30333.01.01
|
ESBRIET CAPS 267MG/CAP BTx63 (1x21) και (1x42) σε PVC/PE/PCTFE/alu blister
|
|
434,66 € |
483,43 € |
558,56 € |
Roche Registration Ltd
|
|
30333.02.10
|
ESBRIET F.C.TAB 267MG/TAB 252 (84x3) δισκία σε BLISTER (PVC/Aclar(PCRFE)) - πολυσυσκευασία
|
|
1.745,17 € |
1.941,00 € |
2.124,32 € |
Roche Registration Ltd
|
|
30333.02.07
|
ESBRIET F.C.TAB 267MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCRFE))
|
|
438,14 € |
487,31 € |
563,04 € |
Roche Registration Ltd
|
|
30333.02.09
|
ESBRIET F.C.TAB 267MG/TAB Θεραπεία έναρξης 63 (1x21 & 2x21) δισκία σε BLISTER (PVC/Aclar(PCRFE)
|
|
438,14 € |
487,31 € |
563,04 € |
Roche Registration Ltd
|
|
30333.04.02
|
ESBRIET F.C.TAB 801MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCTFE))
|
|
1.754,97 € |
1.951,89 € |
2.136,25 € |
Roche Registration Ltd
|
|
22874.01.01
|
INVIRASE 200MG/CAP CAPS FLx270
|
|
194,47 € |
223,53 € |
270,01 € |
Roche Registration Ltd
|
|
23564.04.01
|
MABTHERA INJ.SOL 1600MG/13.4ML BTxVIAL
|
|
1.708,02 € |
1.899,67 € |
2.079,09 € |
Roche Registration Ltd
|
|
22896.06.01
|
NEORECORMON (MULTIDOSE) PS.INJ.SOL 50000 IU/VIAL BTX1VIAL+1AMPX10ML
|
|
176,09 € |
179,61 € |
221,89 € |
Roche Registration Ltd
|
|
22896.15.01
|
NEORECORMON 10000 IU/0,6MLPREF.S INJ.SO.PFS BTx1PREF.SYR.x0,6ML
|
|
35,22 € |
40,48 € |
44,38 € |
Roche Registration Ltd
|
|
22896.12.01
|
NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML
|
|
7,48 € |
7,63 € |
9,43 € |
Roche Registration Ltd
|
|
22896.12.02
|
NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx6PREF.SYRx0,3ML
|
|
43,96 € |
44,84 € |
55,40 € |
Roche Registration Ltd
|
|
22896.16.01
|
NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx1PREF.SYR.x0,6ML
|
|
70,44 € |
71,85 € |
88,76 € |
Roche Registration Ltd
|
|
22896.16.02
|
NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx6 PREF.SYR.x0,6ML
|
|
422,61 € |
431,06 € |
491,03 € |
Roche Registration Ltd
|
|
22896.20.01
|
NEORECORMON INJ.SO.PFS 30.000IU/0,6ML PREF.SY BTx1PF.SYR.x0,6ML
|
|
109,25 € |
111,44 € |
137,67 € |
Roche Registration Ltd
|
|
22896.13.01
|
NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx1PREF.SYRx0,3ML
|
|
10,63 € |
10,84 € |
13,39 € |
Roche Registration Ltd
|
|
22896.13.02
|
NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx6PREF.SYR.x0,3ML
|
|
65,55 € |
66,86 € |
82,60 € |
Roche Registration Ltd
|
|
22896.18.02
|
NEORECORMON INJ.SO.PFS 4000 IU/0,3MLPREF.SY BTx6PF.SYR.x0,3ML
|
|
87,23 € |
88,97 € |
109,91 € |
Roche Registration Ltd
|
|
22896.10.01
|
NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX1PREF.SYR.X0,3ML
|
|
3,47 € |
3,54 € |
4,37 € |
Roche Registration Ltd
|
|
22896.10.02
|
NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX6PREF.SYR.X0,3ML
|
|
16,49 € |
16,82 € |
20,78 € |
Roche Registration Ltd
|
|
22896.14.01
|
NEORECORMON INJ.SO.PFS 5000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML
|
|
17,61 € |
17,96 € |
22,19 € |
Roche Registration Ltd
|
|
22896.19.02
|
NEORECORMON INJ.SO.PFS 6000 IU/0,3ML PREF.SY BTx6PREF.SYR.x0,3ML
|
|
130,02 € |
132,62 € |
163,84 € |
Roche Registration Ltd
|
|
25173.05.02
|
PEGASYS IN.SO.PF.P 135MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML
|
|
420,44 € |
467,62 € |
540,29 € |
Roche Registration Ltd
|
|
25173.06.02
|
PEGASYS IN.SO.PF.P 180MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML
|
|
484,32 € |
538,66 € |
616,66 € |
Roche Registration Ltd
|
|
25173.03.01
|
PEGASYS INJ.SOL 135MCG/0,5ML BTx1PF.SYR.x0,5ML+1 INJ.N
|
|
105,11 € |
120,82 € |
148,56 € |
Roche Registration Ltd
|
|
28716.01.04
|
ROACTEMRA 20MG/ML BTx4 VIALS x10ML
|
|
1.114,87 € |
1.137,17 € |
1.243,04 € |
Roche Registration Ltd
|
|
28716.01.06
|
ROACTEMRA 20MG/ML BTx4 VIALS x20ML
|
|
2.196,26 € |
2.240,19 € |
2.417,75 € |
Roche Registration Ltd
|
|
28716.01.02
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx4 VIALS x4ML
|
|
439,30 € |
488,59 € |
564,51 € |
Roche Registration Ltd
|
|
25757.03.01
|
TAMIFLU CAPS 30MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
6,83 € |
7,85 € |
10,82 € |
Roche Registration Ltd
|
|
25757.04.01
|
TAMIFLU CAPS 45MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
11,32 € |
13,01 € |
17,92 € |
Roche Registration Ltd
|
|
25757.01.01
|
TAMIFLU CAPS 75MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
11,08 € |
12,73 € |
17,54 € |
Roche Registration Ltd
|
|
25757.02.01
|
TAMIFLU PD.ORA.SUS 12MG/ML BTx1Φιάλη (γυάλινη)
|
|
11,85 € |
13,62 € |
18,77 € |
Roche Registration Ltd
|
|
25757.05.01
|
TAMIFLU PD.ORA.SUS 6MG/ML BT x 1Φιάλη (γυάλινη) x 13G
|
|
7,51 € |
8,63 € |
11,89 € |
Roche Registration Ltd
|
|
27001.01.01
|
TARCEVA 25mg/TAB F.C.TAB BT x 30 (BLISTERS, PVC/Alu)
|
|
374,19 € |
430,10 € |
438,43 € |
Roche Registration Ltd
|
|
27001.02.01
|
TARCEVA F.C.TAB 100 mg/TAB BTx 30 (BLISTER, PVC/Alu) (BLISTER, PVC/Alu)
|
|
1.192,48 € |
1.326,28 € |
1.465,61 € |
Roche Registration Ltd
|
|
27001.03.01
|
TARCEVA F.C.TAB 150mg/TAB BT x 30 (BLISTERS, PVC/Alu) (BLISTERS, PVC/Alu)
|
|
1.484,82 € |
1.651,43 € |
1.816,16 € |
Roche Registration Ltd
|
|
23551.03.01
|
VIRACEPT F.C.TAB 250MG/TAB FLX270
|
|
223,74 € |
257,17 € |
305,84 € |
Roche Registration Ltd
|
|
23551.01.01
|
VIRACEPT ORAL.PD 50MG/G FLX144G
|
|
30,22 € |
34,74 € |
48,99 € |
Roche Registration Ltd
|
|
23457.01.02
|
XENICAL CAPS 120MG/CAP BTX42(BLISTERS)
|
|
13,19 € |
15,16 € |
21,38 € |
Roche Registration Ltd
|
|
23852.02.01
|
ZENAPAX 1 BOX * 3 VIAL * 5 ML
|
|
|
|
|
Roche Registration Ltd
|
